Company Research Report: 4baseCare



Company Overview


  • Name: 4baseCare

  • Mission: To provide cancer patients with the best chance of fighting cancer using advanced genomic solutions and next-gen digital technology.

  • Founded: No information is available

  • Founders: No information is available

  • Key People:

  • Hitesh Goswami, Co-Founder & CEO

  • Kshitij Rishi, Co-Founder & COO

  • Dr. Giridharan Periyasamy, Chief Scientific Officer

  • Praveen Jha, Vice President - Commercial Operations

  • Dr. Sudharshan Elangovan, Vice President-Global Operations & Regulations

  • Dr. Anjali Kulkarni, Vice President - RWE Strategy and Analytics

  • Sreekanth Tangirala, Head of Engineering

  • Dr. Vidya H Veldore, Vice President-Clinical Operations

  • Advisors:

  • Francis deSouza, former CEO & Co-Founder of SynthLabs

  • Lip-Bu Tan, Chairman of Walden International and Founding Managing Partner at Walden Catalyst Ventures

  • Headquarters: No information is available

  • Number of Employees: No information is available

  • Revenue: No information is available

  • Known For: Developing precision oncology solutions using advanced genomics and digital health technology. They are noted for their comprehensive genomic panels for targeted cancer therapy.


Products



1. TARGT Indiegene


  • Description: One of the largest cancer gene panels developed by profiling the whole exome and transcriptome.

  • Key Features:

  • Targets cancer gene mutations specific to the Indian population.

  • Profiles over 1,212 unique genes.


2. OncoBuddy


  • Description: A digital healthcare platform providing holistic support to cancer patients.

  • Key Features:

  • Offers community support and virtual consultations.

  • Provides a personal health record manager for clinical records.


3. SoLiQ Panels


  • Description: Combines solid and liquid biopsies for comprehensive genomic profiling.

  • Key Features:

  • Integrates solid and liquid biopsy data.

  • Enhances mutation detection accuracy.


4. Hereditary Cancer Gene Panel


  • Description: Panel to analyze genes known for hereditary cancer risk.

  • Key Features:

  • Profiles genes associated with increased cancer risk.

  • Provides personalized treatment options.


Recent Developments


  • New Product Launches:

  • Launched TARGT Indiegene, an Indian population-specific cancer gene panel.

  • Funding and Partnerships:

  • Raised $6 million in Series A funding led by Yali Capital.

  • Partnered with Wipro to improve genomic testing accessibility and reduce turnaround time.

  • Received a 5 Million INR Biotechnology Ignition Grant for AI-based precision oncology solutions.

  • Advisory and Leadership:

  • Lip-Bu Tan and Francis deSouza joined the advisory board, enhancing strategic growth initiatives.

  • Upcoming Expansion:

  • Plans to set up genomics laboratories in the Philippines, Nepal, and Dubai.

  • New Collaborations:

  • Partnered with Innovate Life Sciences at Dubai Science Park to enhance genomic research for precision oncology.


Conclusion



4baseCare is poised as a leader in precision oncology, leveraging genomics and digital technology to personalize cancer treatment. Despite the lack of detailed financial and operational data, strategic partnerships and funding developments indicate robust growth and expansion efforts across Asia and the Middle East. The company's mission to bridge genomic data gaps in these regions highlights its potential impact on the global cancer treatment landscape.